Clinical Aesthetics And Investigative Management Service Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 17-07-2024
- Paid Up Capital ₹ 3.28 M
as on 17-07-2024
- Company Age 17 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.00 M
as on 17-07-2024
- Revenue -12.90%
(FY 2023)
- Profit -82.37%
(FY 2023)
- Ebitda -71.69%
(FY 2023)
- Net Worth 3.82%
(FY 2023)
- Total Assets 2.36%
(FY 2023)
About Clinical Aesthetics And Investigative Management Service
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 3.28 M.
The company currently has active open charges totaling ₹6.00 M.
Priti Mohile, Rashmikant Mohile, and Dilip Modi serve as directors at the Company.
- CIN/LLPIN
U85100MH2007PTC172278
- Company No.
172278
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jul 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Clinical Aesthetics And Investigative Management Service?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Priti Mohile  | Director | 12-Jul-2007 | Current |
| Rashmikant Mohile | Director | 12-Jul-2007 | Current |
| Dilip Modi | Director | 10-Oct-2007 | Current |
Financial Performance of Clinical Aesthetics And Investigative Management Service.
Clinical Aesthetics And Investigative Management Service Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 12.9% decrease. The company also saw a substantial fall in profitability, with a 82.37% decrease in profit. The company's net worth moved up by a moderate rise of 3.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Clinical Aesthetics And Investigative Management Service?
In 2023, Clinical Aesthetics And Investigative Management Service had a promoter holding of 75.88% and a public holding of 24.12%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Orac Lifesciences Private LimitedActive 18 years 29 daysPriti Mohile and Rashmikant Mohile are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of Hyderabad Creation Date: 23 Feb 2008 | ₹6.00 M | Open |
How Many Employees Work at Clinical Aesthetics And Investigative Management Service?
Unlock and access historical data on people associated with Clinical Aesthetics And Investigative Management Service, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Clinical Aesthetics And Investigative Management Service, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Clinical Aesthetics And Investigative Management Service's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
